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Introduction 
Purpose of the introduction 
The purpose of the introduction is to inform the reader about  
• the background for this thesis  
• functional dyspepsia; prevalence, pathologic findings and existing theories of 
pathophysiology  
• the vagal nerve; mainlines of its role in normal gastrointestinal physiology and 
different methods to measure vagal activity 
• methods for studying gastric function 
• lifestyle and stress; definitions, lifestyle diseases and protecting factors 
Background 
The diagnosis functional dyspepsia is considered a heterogeneous disorder (1). There is no 
specific pathologic finding that is characteristic for all patients with this diagnosis, and there 
is no effective treatment available. Functional dyspepsia is often related to stress (2) and low 
vagal tone (3-5), and stress is implicated in several lifestyle diseases (6), giving the hypothesis 
that functional dyspepsia itself is a lifestyle disorder and that changes in lifestyle will improve 
the condition.  
Functional dyspepsia 
Definition of functional dyspepsia 
Dyspepsia is derived from Greek and literally means “bad digestion” (dys=bad, 
peptein=digestion). Functional dyspepsia is by the Rome II declaration defined as: At least 12 
weeks, which need not be consecutive, in the preceding 12 months of: 1. Persistent or 
recurrent upper, central, abdominal pain or discomfort. 2. No evidence of organic disease 
(including upper endoscopy) that is likely to explain the symptoms. 3. No evidence that 
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dyspepsia is exclusively relieved by defecation or associated with the onset of a change in 
stool frequency or stool form (i.e., not irritable bowel syndrome) (7).  
Based on symptoms, functional dyspepsia has been sub-classified into ulcer-like 
(symptoms suggesting peptic ulcer), dysmotility-like (symptoms suggesting gastric stasis), 
reflux-like (retrosternal symptoms) and idiopathic (not fitting into any of the other groups). 
However, many patients belong to several of the subgroups, and the sub-classification has not 
proven useful with regard to therapeutic or prognostic implications (8, 9). Therefore, the 
patients were not sub-classified in this work.  
Infection with Helicobacter pylori is not taken into consideration in this thesis, as it 
seems to have no impact on symptoms or gastric sensory-motor functions in patients with 
functional dyspepsia (10). 
Prevalence, incidence and prognosis 
Approximately 14-38% of the adult population in Western countries is affected by dyspepsia 
(11-13). Incidence of dyspepsia is approximately 11-20% (11, 12), however, about 13-18% 
have spontaneous resolution during a year (11, 12), leaving prevalence stable over time (11-
13).  
Patients with dyspepsia account for some 30% of consultations to specialist 
gastroenterologists (13-15). The prevalence of functional dyspepsia among patients with 
symptoms arising from the upper gastrointestinal tract is reported to range from 19-76% (14). 
Functional dyspepsia affects quality of life negatively (16). Hence, functional dyspepsia 
represents a substantial source of morbidity, as well as considerable financial burden on the 
healthcare system. 
Pathophysiology  
Patients with functional dyspepsia often experience epigastric pain or discomfort, early 
satiety, fullness and nausea in relation to meals. Epigastric discomfort may be perceived when 
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the tension in the stomach wall is increased as a consequence of inadequate relaxation (17-
19). The fact that the symptoms often begin during the first 2-3 min of a meal (20), before 
maximal meal-induced relaxation has taken place (normally 5-12 min after a meal (21)), 
suggests that stretch-receptors in the muscularis propria of the gastric wall are activated (22). 
Many of the patients with functional dyspepsia have indications of gastric motor or 
sensory dysfunctions, such as hypersensitivity to distension (23-25), impairment of 
accommodation to meals  (23, 26, 27) or delayed emptying (15). Low vagal tone is found 
more often than normal in these patients (3-5). Vagotomy leads to impairment of fundic 
relaxation (28). Thus, the impairment of accommodation to meals in patients with functional 
dyspepsia might be due to low vagal tone.  
The low vagal activity found in patients with functional dyspepsia might be a 
consequence of stress, because vagal tone decreases after acute mental stress in both patients 
with functional dyspepsia and healthy controls (4, 29), and patients with functional dyspepsia 
have more chronic stress than controls (30). Low vagal tone also has been suggested as a 
mediating mechanism by which psychological factors like neuroticism and anxiety induce 
dyspepsia in these patients (3, 4, 17). In patients with functional dyspepsia there is a 
significant negative correlation between neuroticism and low vagal tone (3). The patients have 
as a group more anxiety, depression, neuroticism, somatisation and experience more negative 
life events and chronic stress than controls (3, 30).  
Thus, it seems like there might be a vicious cycle in functional dyspepsia (17), where 
psychological factors like anxiety, stress and neuroticism induces vagal suppression, which 
gives impaired gastric accommodation, inducing visceral hypersensitivity, which might 
produce central sensitisation maintaining physiological and psychological factors. Breaking 
this circle at any of the points might resolve the whole problem. In this project, the focus is on 
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the vagal nerve, as it, in this conceptual framework, is the connecting link between gut and 
brain. 
The vagal nerve is a bidirectional connection between the brain and the immune 
system. In the intestine, mast cells and macrophages may be activated by stress and release 
histamine and inflammatory cytokines, which trigger sensory fibres of the vagal nerve lying 
close by (31, 32). The nerve conveys ascending signals to nucleus tractus solitarius in the 
brain stem (32). The brain processes the information and activates efferent vagal fibres. This 
vago-vagal reflex may influence the control of the peripheral immune system, by the so-called 
anti-inflammatory pathway. It has been shown that effector neurons originating in the dorsal 
motor nucleus of the vagal nerve can inhibit the production of pro-inflammatory cytokines of 
tissue macrophages through a mechanism dependent on the α7 nicotinic acetylcholine 
receptor (33, 34). Theoretically, an underlying defect in the activity of the cholinergic anti-
inflammatory pathway, i.e. vagal nerve, might then trigger an over-production of cytokines 
from macrophages and other pro-inflammatory cytokine producing cells in response to an 
otherwise harmless immunological stimulation.  
Pain stimuli caused by stress is first transmitted upward through the brainstem to the 
perifornical area of the hypothalamus and from here into the paraventricular nucleus of the 
hypothalamus and eventually to the median eminence, where corticotrophin releasing factor 
(CRF) is secreted to the primary capillary plexus of the hypophysial portal system and then 
carried to the anterior pituitary gland, where it induces ACTH secretion. ACTH activates 
adrenocortical cells to produce cortisol. Mental stress also can cause ACTH secretion. This is 
believed to occur through the limbic system, especially in the region of the amygdala and 
hippocampus, both of these transmitting signals to the posterior medial hypothalamus. All 
these responses happen within a few minutes. (35) 
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Inhibition of gastric emptying and stimulation of colonic motor function are the 
commonly encouraged patterns induced by various stressors. CRF receptor 1 and 2 is found in 
human colon tissue (36), and CRF receptor 2 is found in human stomach (37), suggesting that 
activation of the CRF receptor 1 in the colon is stimulating its propulsive activity, while 
activation of the CRF receptor 2 in the stomach leads to inhibition of the gastric emptying rate 
(38). CRF is acting centrally as well, as it decreases gastric vagal outflow (39). Thus CRF 
delays gastric emptying via both central and peripheral mechanisms. Patients with functional 
dyspepsia have increased stress level, and possibly increased CRF secretion, and the central 
mechanism of CRF might explain their low vagal tone. 
Thus, the pathogenesis of functional dyspepsia might be based on stress, leading to 
CRF induced low vagal tone, preventing the body to control inflammation in the gut released 
by triggering events like stress, inflammation or trauma. This might result in visceral 
hypersensitivity, and the patient may enter the vicious circle of functional dyspepsia.  
The vagal nerve 
Vagal nerve and gastrointestinal physiology 
The motility of the gut and digestive secretory activity are regulated by the enteric nervous 
system in the gut wall, which constitutes a semiautonomous neural network control system. 
The enteric nervous system is composed mainly of two complexes; the Auerbach’s plexus (or 
myenteric plexus) located between the circular and the longitudinal muscle layers, and the 
Meissner’s plexus (or submucosal plexus) located in the submucosa. Auerbach’s plexus 
mainly controls motility, and the Meissner’s plexus mainly controls gastrointestinal secretion 
and local blood flow. The plexuses are innervated with postganglionic sympathetic nerve 
fibres from the splancnic nerves and with preganglionic parasympathetic nerve fibres from the 
vagal nerve. The sympathetic neurotransmitter is epinephrine, and the parasympathetic 
neurotransmitter is acetylcholine.  
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Sensory neurons transmit information from the gut to the enteric nervous system and 
to the central nervous system through the vagal nerve and sympathetic nerve fibres. Feedback 
responses to the gut go through efferent fibres from the central nervous system to the gut in 
the vagal nerve, and through sympathetic fibres from the prevertebral sympathetic ganglia 
back to the gastrointestinal tract. There are also feedback responses within the enteric nervous 
system itself. (40) 
Vagal activity is of great importance for the regulation of the tone in the gastric wall. 
During fasting, gastric tone is maintained by cholinergic stimulation (40, 41). In response to a 
meal, the gastric musculature relaxes and the tone is reduced. This relaxation of the proximal 
stomach is controlled by nitrergic inhibition (nitric oxide as neurotransmitter) of cholinergic 
vagal efferent pathways (42, 43), also called a non-adrenergic, non-cholinergic vago-vagal 
reflex (44). The relaxation of the body and fundus enables the stomach to maintain a low 
balanced pressure and to continuously adapt its volume to its content (45).  
Measurements of vagal activity 
In man, only indirect methods for measuring vagal activity exist. Commonly used methods for 
measurement of gastric vagal activity are increase of gastric acid secretion (46) or pancreatic 
polypeptide level (47) in response to insulin-induced hypoglycaemia. Commonly used 
methods for measurement of cardiac vagal activity are various measures of heart rate 
variability (29, 48, 49).  
Gastric vagal activity 
Gastric acid is secreted by parietal cells which are located in the corpus and fundus areas of 
the stomach. The physiologic stimulation of acid secretion has been divided into three phases; 
cephalic, gastric and intestinal. The cephalic phase is activated by the thought, smell, taste and 
swallowing and is mediated through cholinergic/vagal mechanisms. The gastric phase is the 
responses to gastric distension and chemical effects of food, stimulating the gastrin cells/G-
cells in the antral mucosa to release gastrin, which is transported via the blood to stimulate 
 15
histamine release from the enterochromaffin-like (ECL) cells (50, 51) located in the corpus 
and fundus areas of the stomach in direct proximity to the parietal cells. ECL cell histamine is 
probably the major physiological mediator of acid secretion (52). The observation that H2 
(histamine) receptor antagonists block the cephalic and gastric phases underscores the 
importance of histamine mediation of the stimulatory response (53), and illustrates the 
interdependence of the different phases. The intestinal phase accounts for only a small 
proportion of the acid secretory response to a meal, and its mediators remain controversial.  
Pancreatic polypeptide is secreted from the duodenal part of the pancreas (54) in 
response to vagal cholinergic stimulation (47, 55). The response is abolished by vagotomy 
and atropine (47). Released pancreatic polypeptide enters systemic circulation and travels to 
the dorsal vagal complex in the brainstem, where it suppresses efferent vagal signals by 
negative feedback as digestion of the meal progresses (56).  
Cardiac vagal activity 
In animals, the non-invasive methods of cardiac vagal activity have shown nearly 100% 
linearity with invasive measures of efferent cardiac vagal activity (48).  
For measuring heart rate variability, Sayers (57) performed spectral analysis and 
detected three peaks which were denoted very low-frequency (<0.05 Hz), low-frequency 
(0.05-0.15 Hz) and high-frequency (0.15-0.5 Hz). The very low frequency was considered to 
relate to body temperature. The low-frequency, also called the Mayer Wave-related sinus 
arrhythmia, is related to the regulation of blood pressure and reflects the combined activity of 
the sympathetic and parasympathetic nervous system (58, 59). The high frequency domain of 
heart rate variability, also called respiratory sinus arrhythmia, is caused by respiration and 
reflects the activity of the parasympathetic nervous system. In addition to using spectral 
analysis, respiratory sinus arrhythmia can also be measured as “peak-to-valley” differences. 
Studies by Grossman et al. (60) and Hayano et al. (61) have shown that the tests provide much 
the same information, and the results therefore can be considered almost interchangeable.  
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Spectral analysis is based on data-logged electrocardiographic (ECG) signals. From 
the ECG, the series of R-R intervals is calculated as a function of the beat number. In other 
words, the R-R interval measured in seconds is on the y-axis and the beat number on the x-
axis. Then the frequency distribution of the R-R intervals is calculated, and from this the 
spectral analysis is composed (62). 
The peak-to-valley (or peak-to-trough) method assesses, on a breath-by-breath basis, 
the difference between the shortest R-R interval/highest pulse corresponding to inspiration 
and the longest R-R interval/lowest pulse corresponding to expiration (29). 
Different methods for measuring gastric accommodation  
Gastric accommodation is a process by which the stomach adapts to a meal without increase 
in pressure by relaxing the proximal part of the stomach through non-adrenergic non-
cholinergic vago-vagal reflexes. The reflexes are provoked by chemoreceptors in the 
duodenum and mechanoreceptors and tension receptors in the stomach.  
The “gold standard” for studying gastric accommodation to a meal has been the 
barostat method (27). Thanks to its close contact with the gastric wall, the barostat bag adjusts 
to changes in proximal gastric pressure by changing the intrabag volume. Thus, changes in 
volume are believed to reflect changes in muscle tone of the wall. However, introducing the 
barostat balloon into the gastric lumen may influence the gastric motility patterns (21, 63-65), 
and the examination is invasive and unpleasant. Neither the barostat nor scintigraphy allows 
estimation of the size of the proximal stomach. On the contrary, ultrasound and single photon 
emission computer tomography (SPECT) scanning can detect changes in gastric volume in a 
non-invasive manner. Like ultrasound, SPECT scanning is a non-invasive alternative to the 
barostat in evaluating gastric relaxation. However, in comparison with meal induced volume 
increase, SPECT scanning failed to detect the profound gastric relaxation following glucagon 
infusion (66). These findings suggest that SPECT scanning is less suitable than the gastric 
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barostat in detecting gastric relaxation and rather detects the volume of the intragastric 
contents after meal intake. Imaging methods visualise directly the size of the gastric 
compartments, thus giving an indirect measure of relaxation and contraction. The volume 
change seen using imaging can thus be explained by additional secretion, air retention in 
addition to changes in gastric emptying. 
An important question is whether measures obtained by imaging methods, such as 
SPECT or ultrasonography, can actually be compared to the measurements made by the 
barostat. The gastric meal accommodation process has two components: Passive meal 
distension of the gastric compartments and active muscle relaxation of the gastric wall. The 
first component is best measured with imaging methods whereas the barostat is best suited for 
studying the second component. Imaging methods at this stage do not distinguish between 
enlargement of the stomach due to reflex relaxation and that due to meal-induced distension; 
it just measures the totally accommodated volume. Accordingly, it may not be adequate to 
compare imaging methods and the barostat method for validation of gastric accommodation. 
Gastric accommodation depends on neuromuscular factors and hence also concerns the 
mechanical properties of the stomach. In this sense the barostat merely detects the existence 
of change in wall tone, but cannot, like imaging methods, provide data on the distribution of 
the volume and the normal behaviour of the gastric wall. It seems essential to carefully choose 
the most suitable method for the issue (distension or muscular relaxation) being studied.  
Stress and lifestyle 
In medicine, stress refers to a set of bodily reactions to physical, psychic, infectious and other 
natural aggressors capable of disturbing homeostasis. It is generally believed that biological 
organisms require a certain amount of stress in order to maintain their well-being. However, 
when stress occurs in quantities that the system cannot handle, it produces pathological 
changes (Taber’s cyclopedic medical dictionary). Hans Selye, a pioneer in the study of stress 
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who recognised the mind-body connection and started studying stress biologically in 1936, 
named these pathological changes the General Adaptation Syndrome (GAS) or stress 
syndrome, and divided the GAS into three phases:  
1) The alert or alarm reaction phase – the initial response to an aggressive agent.  
2) The resistant phase – the body’s attempt to adapt to the presence of the aggressor, 
producing organic changes.  
3) The exhaustion or decompensation phase – the body fails to eliminate an aggressive 
agent (67). 
Stress is a part of a modern lifestyle. Lifestyle is our relation to food, exercise, drugs, 
our attitudes and our self-created environments, and it is responsible for about 50% of death 
causes (68). Using 8 keys for health, (NEW START: Nutrition, Exercise, Water, Sunshine, 
Temperance, Air, Rest, Trust in God) Seventh-day Adventists live longer than the general 
population. In the Adventist Health study, studying mortality of 34 192 California Adventists 
from 1976 to 1988, men lived approximately 7.3 years longer than the average white 
California man, and women Adventists lived 4.4 years longer (69). No history of smoking, 
avoidance of overweight, regular physical activity, nut consumption and a vegetarian diet 
were each associated independently with longer median life expectancy (69). Vegetarian 
Adventists have lower risk for developing colon cancer, diabetes, coronary artery disease, 
hypertension, overweight and arthritis (70). 
Using a questionnaire developed at our institute (71), we found that patients with FD 
had about similar lifestyle as healthy controls (unpublished data). In this work, we only 
studied the lifestyle factors related to general relaxation and meal ingestion.  
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Aims of the project 
The overall aim of the project was to study whether simple changes of lifestyle (velocity of 
ingestion, breathing pattern, body position) can change vagal activity, accommodation of the 
stomach to a meal and meal-related discomfort.  
The specific aims of the four papers included in this thesis were: 
I. To study factors that influence vagal tone and whether vagal tone is related to abdominal 
symptoms in response to meal ingestion in healthy subjects. 
II. To compare the diagnostic ability of various test meals in our drink test paradigm in 
functional dyspepsia. 
III. a) To see if enhancement of vagal activity by insulin-induced hypoglycaemia in healthy 
subjects would influence gastric emptying and intragastric volumes as measured by 
three-dimensional ultrasonography.  
b) To see if peak-to-trough method of heart rate variability, i.e. respiratory sinus 
arrhythmia, measured during hypoglycaemia would follow the increase in pancreatic 
polypeptide in healthy subjects.  
IV. To investigate whether enhancement of vagal tone by breathing exercises and vagal 
biofeedback would beneficially influence drinking capacity, intragastic volumes, gastric 
emptying, dyspepsia-related quality of life and baseline autonomic activity in patients 
with functional dyspepsia.  
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Materials and methods 
An overview of study designs, interventions, subjects, test meals and measurements are given 
in table I. More details are outlined here and in the papers. 
Ethics 
The studies were approved by the Regional Committee for Medical Research Ethics, and were 
conducted in accordance with the revised Declaration of Helsinki. All participants gave a 
written, informed consent to participate in all the trials. 
Subjects 
In paper I, 40 healthy subjects, 20 men and 20 women, were recruited among university 
students in the city of Bergen in Norway. The median age was 23 years (range 19 to 38 
years). In paper II, 10 healthy subjects (male/female 4/6, median age 29.5, range 19-37 years, 
mean BMI 21.2±1.7 kg/m2) and 10 patients with functional dyspepsia (male/female 3/7, 
median age 31, range 18-40 years, mean BMI 23.3±2.8 kg/m2) were included. In paper III, 20 
healthy volunteers (male/female 10/10, median age 24, range 22-27 years, mean BMI 
23.2±2.5 kg/m2) were recruited among medical students in Bergen, Norway. In paper IV, 40 
patients with functional dyspepsia were included (male/female 8/32, mean age 35.3±12.4 
years, BMI 23.1±3.6 kg/m2).  
All patients fulfilled the Rome II criteria and were recruited from the out-patient clinic 
at Haukeland University Hospital in the city of Bergen in Norway. Healthy subjects were 
eligible if they defined themselves as healthy, were 18 years of age or older, were non-
pregnant and did not abuse alcohol or drugs. 
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Methods 
Table 1. Overview of study designs, interventions, subjects, test meals and 
measurements 
         Paper I Paper II Paper III Paper IV 
     
Design Prospective, 
ABA-design,  
non-blinded 
Prospective, 
case-control, 
randomised, non-
blinded 
Prospective, 
randomised, non-
blinded 
Prospective, 
randomised, non-
blinded, 
biofeedback 
group and control 
group 
     
Intervention Two different 
drinking speeds 
Three different 
test meals 
Insulin in saline 
and saline 
infusions 
Breathing 
exercises and 
biofeedback 
     
Healthy 
Volunteers 
N=40 N=10 N=20  
     
FD Patients   N=10  N=40 
     
Drink tests 500 ml Toro® 
clear meat soup 
Nutridrink®, 
Toro® clear meat 
soup and water 
Toro® clear meat 
soup 
Toro® clear meat 
soup 
     
Ingestion rate 1 and 4 min 100 ml/min 100 ml/min 100 ml/min 
     
RSA X  X X 
     
SC   X X 
     
Tree-dimensional 
Ultrasound 
 X X X 
     
PP   X  
     
Questionnaires Symptoms (VAS) 
nausea, 
discomfort, 
fullness, 
epigastric pain 
Symptoms (VAS) 
nausea, fullness, 
epigastric pain 
Symptoms (VAS) 
nausea, fullness, 
epigastric pain 
SF-NDI, EPQ-N, 
TDS, SHQ-6, 
Music 
questionnaire 
     
 
Abbreviations: ABA= test meal in 1 min, then 4 min and again in 1 min; FD = functional dyspepsia; 
RSA = respiratory sinus arrhythmia; SC = skin conductance; PP = pancreatic polypeptide; VAS = 
visual analogue scales; SF-NDI = short form Nepean dyspepsia index; EPQ-N = neuroticism subscale 
of the Eysenck personality questionnaire; TDS = telic dominance scale; SHQ-6 = sense of humour 
questionnaire 
 
Respiratory Sinus Arrhythmia (RSA) 
RSA was measured in paper I, III and IV. Cardiac vagal nerve function was evaluated non-
invasively by a computerised polygraph (Synectics® software and polygraph, Medinor® 
Oslo, Norway) recording the RSA in beats/min. The R-R interval in the ECG was registered 
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by the computer and transformed into beats per minute. Three Ag/AgCl electrodes were 
attached to the thorax, two of them 2-3 cm under the right and left clavicular bones, and the 
third at the left 5th intercostal space in the midclavicular line. The computer recorded 
respiratory movements simultaneously using a pressure-sensible sensor attached to the thorax. 
Recordings were stored in digital format on a computer hard disk for off-line scoring. This 
method calculates the average of peak-to-valley changes of heart rate within 6 successive 
respiratory cycles (29, 49).  
In paper I, time periods 15 min before the test meal and 2 min after the meal were 
chosen for assessment of RSA. In paper III and IV, RSA was assessed for 5 minutes 
immediately before and after the test meal, and RSA was calculated from the last 2 minutes of 
each assessed period. 
Pancreatic Polypeptide (PP) 
PP was measured in paper III. Blood samples were collected from a vein in the right elbow in 
10 of the subjects before start of infusion of saline, before infusion of saline with insulin, after 
30 minutes of saline infusion, and during the glucose clamp procedure. Because of the 
glycaemic threshold and lag time to response of PP, the samples were collected 15 minutes 
after reaching the 2.3 mmol/l level (72). The samples were immediately put on ice, and after 
blood clotting, the samples were centrifuged at +4oC. Blood serum was then separated and 
kept in a freezer at -80oC until analysis. The blood samples were analysed when all samples 
from all the 10 subjects were collected. The samples were analysed by radioimmunoassay 
(Euro-Diagnostica AB SE-205 12 Malmø, Sweden). The coefficient of variation for the 
analysis was CV%=3.1% (n=8) and CV%=5.0% (n=7). The commercial controls run in the 
analysis were 19.2 pmol/l (expected value 17.1±3.4) and 94.8 pmol/l (expected value 
94.0±15). 
 24 
Skin Conductance (SC) 
In paper III and IV, SC was evaluated non-invasively by a computerised polygraph  
(Synectics® software and polygraph, Medinor® Oslo, Norway). SC, expressed in 
microsiemens (μS), is recording ability to lead electricity on the skin by use of the constant 
current method, and is a measure of sweat secretion on the skin, stimulated by the sympathetic 
part of the autonomic nervous system. Two Ag/AgCl electrodes were attached on the palmar 
side of the third and fourth interphalang on the non-dominant hand. Recordings were stored in 
digital format on a computer hard disk for off-line scoring. SC was assessed concomitantly 
with RSA. Because of technical problems, SC was assessed only in nine subjects in paper III. 
Ultrasonography 
All ultrasound imaging was performed while the subjects were sitting slightly backwards in a 
wooden chair. The applied triplex scanner (System Five Ving Med A/S, Horten, Norway, with 
a 3.5 MHz curved array probe) allowed visualisation of real-time ultrasound images.  
Three-dimensional (3D) ultrasound imaging was performed using previously validated 
methods (73). In the volume range 100 to 700 ml, the 3D system showed excellent agreement 
between estimated and true intragastric volumes with low inter-observer variation (73). The 
3D ultrasound system consisted of the ultrasound scanner (System Five, VingMed Sound A/S, 
Horten, Norway) with a built-in position and orientation measurement (POM) system (Flock 
of Birds Model 6D FOB, Ascension Technology Corp. Burlington, Vermont, USA). The 
POM system is based on a transmitter which produces a spatially varying magnetic field, and 
a small receiver containing three orthogonal coils to sense the magnetic field strength (74). 
Detailed description of the POM system and the calibration procedure is previously reported 
(75). 
The 3D ultrasound acquisition was performed after the test meal, and the subjects were 
instructed to hold their breath and to avoid moving their body. The scanning time normally 
was about 6-7 seconds. The stomach was scanned along its long axis by a continuous 
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translation movement, and scanning started proximally at the left subcostal margin and moved 
distally to the gastroduodenal junction. In this manner, transversal sections of the entire 
stomach were recorded. For each scan approximately 100-130 ultrasound images were stored.  
Gastric emptying was defined as fraction of the test meal emptied from the stomach 
during the meal ((drinking capacity minus intragastric volume) x 100% / drinking capacity). 
Intragastric distribution of the meal was assessed by the ratio of proximal to distal 
volume (75).  
Test meals 
In paper I, the test meal was 500 ml commercially available meat soup ingested in 1 or 4 
minutes (Toro® clear meat soup, Rieber & Søn A/S, Bergen, Norway). It contained 1.8 g of 
protein, 0.9 g of fat, 1.1 g carbohydrate and non-soluble seasoning (0.2 g) per 500 ml. The pH 
of the soup varied between 5.4 and 5.7, and the osmolarity was 350 mOsm/kgH2O. The soup 
was first boiled and then cooled to 37°C.  
In paper II, the test meals were Nutridrink®, Toro® clear meat soup and water 
ingested at a rate of 100 ml/minute until maximal drinking capacity. Nutridrink® (Nutricia 
Norway as, Oslo, Norway), a high-caloric meal (150 kcal/100 ml) tasting vanilla, containing 5 
g protein, 18 g carbohydrate and 6.5 g fat per 100 ml, was ingested room-tempered. The water 
was tapped from the tap, and ingested lukewarm. Toro® clear meat soup was prepared as in 
paper I.  
In paper III and IV the test meal was Toro® clear meat soup ingested at a rate of 100 
ml/minute until maximal capacity. The test meal was prepared as in paper I.  
Biofeedback 
“Freeze-Framer” is computer software that visualizes and evaluates changes in heart rate 
variability in real time. The Freeze-Framer was developed by the Institute of HeartMath under 
the direction of Doc Childre in Boulder Creek, California. The Freeze-Framer monitors the 
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beat-by-beat changes in heart rate with its electronic sensor, which reads the pulse from the 
finger. It plots the speeding and slowing of the heart rate, and analyses the heart rhythm 
pattern. In general, a smoother heart rhythm pattern indicates a balanced nervous system 
whereas an irregular, jagged pattern indicates a less balanced nervous system. The Freeze-
Framer records the degree of smoothness or jaggedness of the heart rhythm and, based on a 
mathematical algorithm, assigns a score. It is possible to increase the smoothness of the heart 
rhythm pattern. This is mainly done through teaching the subjects how to relax, using 
breathing techniques.  
The probe was put on the subject’s second finger, on the non-dominant hand. When 
the breathing exercises were correctly performed, a warm-air-balloon started flying. With 
deterioration of performance, the balloon lost height, and it even landed on the ground if 
performance did not improve. The evaluation of performance, or entrainment ratio, was 
summarized in a red (low entrainment ratio), blue (medium entrainment ratio) and green 
column (high entrainment ratio) with a percentage scale. The training criterion was that the 
patients had, in sum, at least 70% high and medium entrainment ratio. Those who did not 
reach training criterion had to practice breathing technique using the Freeze Framer once a 
week until training criterion was reached, or the treatment period was completed.   
Questionnaires 
In paper I, a questionnaire with visual analogue scale (VAS) for nausea, discomfort, fullness 
and epigastric pain was applied before and after the test meal. Scoring was made on a 10 cm 
unmarked line where a mark at 0 cm expressed “no symptom” and a mark at 10 cm expressed 
“excruciating symptoms”. The total score was the sum of scores for these four symptoms.  
In paper II and III, nausea, fullness and epigastric pain were assessed at maximal 
drinking capacity, using VAS as in paper I, but measured in mm. Sum of scores for nausea, 
fullness and pain at maximal drinking capacity was denoted “pooled symptom score”. The 
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rate by which a symptom was induced was calculated as symptom score at maximal drinking 
capacity divided by ingestion time. 
In paper IV, Norwegian versions of the “Short Form Nepean Dyspepsia Index” (SF-
NDI) (76), “Sense of Humor Questionnaire” (SHQ-6) (77), “Telic Dominance Scale” (78) and 
the Neuroticism subscale of the “Eysenck Personality Questionnaire” (EPQ-N) (79) were 
filled in before investigations at visit 1. At visit 2, SF-NDI was filled in once more. In 
addition, the patients in the biofeedback group filled in a questionnaire to assess liking of the 
music.  
SF-NDI is a disease specific measure of quality of life, with ten questions divided into 
five subscale scores (tension, interference with daily activities, eating/drinking, 
knowledge/control, work/study) and one total score. Each question has five options giving 1-5 
points (1=not at all, 5=extremely). The lowest possible score is 10, and the maximal possible 
score is 50. Arslan et al. found that the score in the general Norwegian population (n=70) was 
13.5±6.8 (80).   
SHQ-6 is measuring the patients’ sense of humour, ability to discover humoristic hints 
and situations, and attitude to humorous others. There are 6 questions, and each question has 
four answer alternatives giving scores 1-4, when summarised gives the total SHQ-6 score. 
The lowest possible score is 6, and the maximal possible score is 24, with a normal value of 
15.5 in urban areas (rural areas 18.8).   
“Telic Dominance Scale” is analysing serious-mindedness, planning orientation and 
arousal avoidance through 42 questions, with 14 questions for each subscale. Mean, or normal 
value of serious-mindedness is 6.4±1.9, planning orientation is 5.6±2.1, and arousal avoidance 
is 6.4±2.3.  
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EPQ-N is scoring neuroticism through 12 Yes/No questions. Answering “Yes” to any 
of the questions gives 1 point, and the possible range of score is 0-12. Normal values are 
varying with sex and age from 4.14 to 6.7.  
The questionnaire to assess liking of the music in the biofeedback group was filled in 
at the first and last day of the treatment, using a ten-step scoring format (1= I strongly dislike 
the music, and 10=I liked the music very much).    
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Summary of results 
Paper I 
Vagal tone and meal-induced abdominal symptoms in healthy subjects 
Scores for nausea and discomfort were higher when the soup was ingested in 1 min as 
compared with 4 min (nausea: P = 0.02; discomfort: P =0.04). There was no difference in 
fullness or abdominal pain. RSA was unrelated to meal-induced symptom scores. RSA varied 
with respiration and body position: It was highest while breathing deeply in the sitting 
position (24.0 beats/min). With normal breathing RSA was highest in the supine position (9.0 
beats/min), lower while sitting (7.0 beats/min) and lowest while standing (6.2 beats/min).  
Paper II 
Drink tests in functional dyspepsia: Which drink is best? 
Drinking capacity (P <0.05) and intragastric volume (P <0.01) were significantly lower in the 
patients than in the controls with the meat soup meal, but not with Nutridrink® or water. 
Gastric emptying distinguished significantly (P <0.05) between patients and controls only 
with Nutridrink®. Gastric emptying of Nutridrink® was significantly correlated to the rate by 
which nausea was induced (P =0.02), while gastric emptying of meat soup was significantly 
negatively correlated to the rate by which fullness was induced (P <0.05). ROC analysis 
indicated that optimal discrimination between patients and controls was obtained by the 
combined test result of symptoms per intragastric volume using meat soup as test meal. 
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Paper III 
Insulin-induced hypoglycemia stimulates gastric vagal activity and motor function 
without increasing cardiac vagal activity 
Insulin-induced hypoglycemia increased drinking capacity (P =0.002), gastric emptying (P 
=0.02), pancreatic polypeptide (P =0.004) and SC (P =0.004), while intragastric volume was 
unchanged (P =0.7) and RSA decreased (P =0.03). 
Paper IV 
Breathing exercises with vagal biofeedback: beneficial for patients with functional 
dyspepsia? 
Drinking capacity and quality of life improved significantly more in the biofeedback group 
than in the control group (P =0.02 and P =0.01) without any significant change in baseline 
autonomic activity (RSA and SC) or intragastric volume. After the treatment period, RSA 
during breathing exercises was significantly correlated to drinking capacity (r=0.6, P=0.008). 
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General discussion 
Important findings in this project were that rapid ingestion of a meal evoked symptoms in 
healthy subjects, and that vagal activity depended on body positions. Vagal activity was 
highest in the supine position, intermediate in the sitting position and lowest during standing. 
In healthy subjects, breathing exercises with slow and deep breathing greatly improved vagal 
activity. The meat soup meal was the best test meal to discriminate between patients with 
functional dyspepsia and healthy controls. In healthy subjects, drinking capacity increased 
significantly during invasive vagal stimulation. Likewise, in patients with functional 
dyspepsia, vagal stimulation using vagal biofeedback with deep breathing improved drinking 
capacity. There was a strong relationship between vagal tone during deep breathing and 
drinking capacity after four weeks of daily breathing exercise. 
Lifestyle factors like general relaxation and speed of meal ingestion seem to impact 
dyspeptic symptoms, quality of life, vagal activity and gastric function. Because vagal activity 
might be a mediating mechanism, people suffering from stomach complaints ought to practice 
deep and calm breathing during the day – if possible in the supine position, as vagal activity is 
highest in this body position, consistent with the fact that parasympathetic activity dominates 
at rest and is lower during labour. In addition, deep breathing may be easier when lying down. 
In this way the vagal nerve increases its activity or ability to fluctuate, for better control of 
stomach function. Then symptoms decline and quality of life increases.  
Dyspeptic patients in general and vagal reflexes in these patients in particular are very 
sensitive to psychological stress. Because functional disorders are so strongly associated to 
psychological factors, we chose to measure gastric function with minimal stress. 
Ultrasonography is a non-invasive procedure that in itself does not distort the physiological 
response in stress-responsive individuals. The examination is also normally performed in a 
quiet and relaxing atmosphere with a minimum of distress. The “stress-factor” is thus minimal 
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with ultrasound, and we chose ultrasonography for studying gastric accommodation in this 
work. 
A non-invasive drink-test for assessment of visceral sensitivity and gastric 
accommodation is a much more convenient diagnostic tool than the invasive and unpleasant 
procedure of the barostat. In patients with functional dyspepsia, early satiety during meals is 
related to impaired gastric accommodation (27). Impaired drinking capacity in patients with 
functional dyspepsia (81-83) may thus be an expression of impaired gastric accommodation. 
However, this is controversial, as Boeckxstaens et al. did not find any relationship between 
drinking capacity and fundic accommodation or visceral hypersensitivity as measured by 
barostat (81), whereas Tack et al. did (84).  Boeckxstaens et al. used an ingestion rate of 100 
ml/min (81) while Tack et al. used 15 ml/min (84). The gastric accommodation reflex is 
elicited both by distension of the stomach and by nutrients in the duodenum, and the reflex 
takes some time (21). Thus, some of the explanation of the disagreeing results might be the 
use of different ingestion rates. Another variant of the drink test is the water load test where 
the subjects drank tap water ad libitum over a five-minute period until reaching fullness (83). 
There is no standard way of performing a drink test, and the ideal drinking rate is not known.  
Healthy subjects get very little symptoms when drinking the 500 ml meat soup meal in 
4 minutes, but drinking the test meal in 1 minute evokes more symptoms (85). In healthy 
subjects, the maximal meal-related gastric relaxation is induced after 5-12 minutes (21). From 
this perspective, it can be assumed that the stomach of healthy individuals adapts so well to a 
meal that they experience few meal-related abdominal symptoms when drinking 500 ml test 
meal in 4 minutes. However, during rapid meal ingestion, the adaptive capability was 
stretched towards its limit, producing symptoms even in healthy subjects. Rapid distension 
may more intensely activate stretch receptors in the muscularis propria of the gastric wall, 
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thereby explaining the higher symptom scores found with rapid than with slow soup 
ingestion.  
Patients with functional dyspepsia get dyspeptic symptoms when drinking 500ml 
Toro® clear meat soup in 4 minutes (4), and symptoms precede the maximal adaptive 
relaxation response (20, 21). This suggests that 4 minutes is close to a threshold in these 
patients. Most of the patients with functional dyspepsia would probably not be able to drink 
500 ml meat soup during 1 minute. For further refinement of the drink test, we figured that 
approaching the limits of drinking capacity would make the test more robust in discriminating 
between patients with functional dyspepsia and healthy subjects. Hence, we chose a drinking 
rate of 100 ml/min. 
The test meals used by others have been water or high-caloric drinks (81, 83, 84). A 
slow high-caloric drink test induces proximal gastric relaxation, while a rapid low-caloric test 
using the meat soup meal, which is a weak stimulus of nutrient induced accommodation, is 
mainly a test of distension induced accommodation and sensitivity to gastric distension, and 
not of nutrient induced gastric accommodation. (21, 82, 84).  
We have used a low-caloric meal, Toro® clear meat soup, and combined the test with 
ultrasonography to study gastric volumes and emptying in addition to the meal-related 
symptoms {Hjelland, 2004 83 /id;Hjelland, 2005 85 /id;Hjelland, 2007 117 /id}. The meat 
soup meal is eminent for ultrasound investigation. Nutridrink® and water are much more 
difficult to see using ultrasonography. In paper II we compared the test meals Nutridrink®, 
water and Toro® clear meat soup. ROC (receiver operating characteristic) analysis indicated 
that drinking capacity, intragastric volume and pooled symptom score after drinking meat 
soup, and gastric emptying of Nutridrink®, discriminated significantly between patients and 
healthy persons. Drink tests with water had poor discriminatory power regardless the variable 
analysed. Pooled symptom score divided by intragastric volume at maximal drinking capacity 
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turned out to be the variable best distinguishing patients from controls. This former measure 
was not used in paper III and IV, as data collection of these studies started before data 
analysis of paper II was completed.  
We found that the perception of nausea was related to the rate of gastric emptying of 
Nutridrink® so that the more Nutridrink® that emptied into the duodenum, the more nausea 
(82). Gastric emptying is inhibited by long chain fatty acids acting on duodenal 
chemoreceptors (88). Teleologically, the slow gastric emptying of Nutridrink® could be a 
consequence of enteric reflexes aiming to avoid nausea. With meat soup the perception of 
fullness was significantly negatively correlated to gastric emptying, i.e., the less meat soup 
emptied into the duodenum, the more fullness. The results suggest that fullness is related to 
distension of the stomach, as also indicated in earlier studies using the gastric barostat (89). 
Water was well tolerated by both patients and controls, but its fast emptying from the stomach 
made intragastric volume assessment difficult, contributing to the poor discriminatory power 
of the test.  It thus appears as if the ideal test meal should be something between water and 
Nutridrink®. In fact, our meat soup meal fits this requirement very well. In spite of its low 
caloric density (40 kcal/L), it induces fed state motility and empties from the stomach at a rate 
slow enough to allow accurate ultrasonographic assessment of intragastric volumes. 
A surprising finding is that intragastric volume did not increase during vagal 
stimulation, neither in healthy subjects during hypoglycaemia, nor during vagal stimulation 
using breathing exercises and vagal biofeedback in patients with FD. Intragastric volume of 
FD patients drinking Nutridrink®, water and meat soup also was remarkably similar. In 
healthy subjects intragastric volume of water and meat soup was about the same, but 
intragastric volume was lower when drinking Nutridrink, possibly due to the high caloric load 
activating chemoreceptors giving nausea. Thus, it seems as if there is a constant individual 
intragastric volume that triggers activation of stretch- and mechanoreceptors of the stomach 
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that via the vagal nerve induce symptoms, encouraging the subject to stop intake of more food 
or liquid.  
The relation between vagal activity and gastric/intestinal motility is complex. There 
are indications of a relationship between poor vagal activity and abnormal gastric motility (3, 
4). There is a positive correlation between vagal activity and proximal gastric size, and a 
negative correlation between vagal activity and antral area (90). Correlation between vagal 
tone and electrogastrogram dominant power, i.e. the myoelectric activity of the intestines, has 
also been found (91). Our findings are consistent with prior studies, as drinking capacity and 
quality of life improved in those receiving vagal stimulation {Hjelland, 2005 85 /id;Hjelland, 
2007 117 /id} and there was a strong relationship between drinking capacity and vagal tone 
during breathing exercises when correct breathing technique was learnt {Hjelland, 2007 117 
/id}.  
It has been suggested that central activation of efferent vagal activity has a parallel 
influence on the heart and the stomach (92). Stimulation of the afferent cardiac vagal nerve 
can induce reflex gastric relaxation and vomiting in the cat, resistant to both atropine and 
guanethidine but not vagotomy (93). RSA increases considerably with deep, calm breathing 
(85), and may also be increased by biofeedback techniques using respiratory techniques to 
influence RSA amplitudes (94). Jokerst et al. found that increasing the parasympathetic 
nervous system activity as measured by RSA by slow diaphragmatic breathing prevented 
development of gastric dysrythmias and decreased symptoms of motion sickness (95). During 
hypoglycaemia, we found that RSA was positively correlated to drinking capacity and 
negatively correlated to nausea while pancreatic polypeptide was not correlated to any of 
these measures (86). This suggests that RSA, and not pancreatic polypeptide, is related to 
perceptions of stomach function. Interestingly, Uijtdehaage et al. found that high levels of 
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cardiac vagal tone were associated with low motion sickness scores (96). The results suggest 
that RSA, as an index of cardiac vagal tone, is related to abdominal vagal tone.  
We found, on the contrary, no correlation between our measures of cardiac (RSA) and 
gastric (pancreatic polypeptide) vagal activity in response to hypoglycaemia (86). The result 
is consistent with prior studies where no correlation was found between RSA and acid output 
in response to insulin-induced hypoglycaemia (97, 98). In prior studies, vagal tone as indexed 
by RSA, decreased after acute mental stress in both patients with functional dyspepsia and 
healthy controls (4, 29). Reduced heart rate variability during vagal stimulation by 
hypoglycaemia could therefore, in part, be due to stress-induced sympathetic activation (5).  
Similarly, increased skin conductance (a measure of sympathetic activation) both 
during glucose clamp hypoglycaemia and during saline infusion, suggests that the procedure 
was perceived stressful, even in the absence of hypoglycaemia (86). Reduced RSA and 
increased pancreatic polypeptide during hypoglycaemia might be consequences of stress-
induced sympathetic activation inhibiting the cardiac but not the gastric vagal drive. Also, 
both hypoglycaemia and insulin may itself release adrenaline and stimulate sympathetic 
activity (99). The net result (the balance between sympathetic and parasympathetic activation) 
might thus seriously depend on the experimental conditions. Schächinger et al. (100) used less 
insulin, a higher glucose level and a longer baseline (and possibly less stress) then we did. 
Contrary to us, they found increased heart rate variability during hypoglycaemia (100). The 
divergent results might be due to different sympathetic activation by the different 
experimental conditions in our study and in the study of Schächinger et al.. 
In patients with functional dyspepsia vagal activity, as measured both by RSA and 
pancreatic polypeptide in response to hypoglycaemia, is assumed to be low (4, 101). As low 
vagal tone might be a key factor for motility disturbances and symptom development in these 
patients, we figured that stimulation of vagal activity might improve symptoms by improving 
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gastric motility. In healthy subjects, vagal stimulation using hypoglycaemia improved gastric 
motility (86). It was, however, a very stressful procedure, not suitable for treatment of patients 
with functional dyspepsia. Stimulation of vagal activity using vagal biofeedback and 
breathing exercises in patients with functional dyspepsia improved quality of life and 
increased drinking capacity {Hjelland, 2007 117 /id}. RSA during breathing exercises was 
positively correlated to drinking capacity solely after the treatment period, not before, 
suggesting that learning correct breathing technique is important. However, although vagal 
tone improved during breathing exercises, “baseline” vagal tone as measured by RSA 
remained unchanged, suggesting no persistent effect on cholinergic control of cardiac 
rhythmic activity. The mechanism by which biofeedback treatment exerted its beneficial 
effects is therefore not clear.  
Lack of maintenance of improvement in vagal tone might be due to too short-lasting 
biofeedback treatments (five minutes a day). Short treatment periods were chosen to improve 
compliance. A prior study, using 1 hour sessions once a week with daily home exercises 
(thermal feedback with breathing exercises + relaxation program) during 8 weeks, has shown 
longer lasting clinical improvement (102). Leahy et al. reported some benefit of treating 
patients with irritable bowel syndrome using 30 min sessions with mental relaxation once a 
week for four weeks, with daily home exercises (103). Denis claimed that the duration of 
feedback sessions cannot be standardised because of the variability of the subjects’ ability of 
learning, their motivation, the pathology and the investigators’ practice (104).  
However, it may be that even increasing duration of treatment does not give persistent 
increased vagal activity. In a small, open study in patients with congestive heart failure, 
Freeze-Framer was used in eight 75 min sessions during 10 weeks with improvements in 
emotional coping and functional capacity, but without any persistent increase in heart rate 
variability (105). We cannot exclude that the increased drinking capacity and quality of life of 
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our patients treated with vagal biofeedback and breathing exercises {Hjelland, 2007 117 /id} 
might be due to other mechanism than increased cardiac vagal activity.  
The quality of life scores improved significantly in the biofeedback group compared 
with the control group {Hjelland, 2007 117 /id}. Sub-analysis revealed that it was only for 
eating/drinking subscale the improvement was significant. Being included in a study 
improved scores for the subscale knowledge/control, independent of group identity. When 
adding vagal biofeedback, eating capacity as well as the ability to enjoy eating and drinking 
were improved.   
Quality of life is influenced by psychological factors such as anxiety and depression, 
which are common in functional dyspepsia and might be part of its pathophysiology (106, 
107). Experimentally induced anxiety inhibits gastric accommodation and increases 
symptoms after a test-meal (108). Respiratory control evokes feelings of peacefulness and 
rest, i.e., the opposite to anxiety (94, 109). Hence, the beneficial influence of our feedback 
therapy on quality of life in patients with functional dyspepsia could be due to anxiety relief 
and not necessarily effects of improved vagal tone. 
Patients with functional dyspepsia do not constitute a uniform group of patients. In 
paper IV, most patients did not have very low vagal tone {Hjelland, 2007 117 /id} as 
compared to other studies using identical method for measuring vagal tone (3-5). In future 
projects using vagal biofeedback and breathing exercises, it might be advantageous to select 
patients with low vagal tone, as they possibly would benefit more from the treatment. 
Learning correct breathing technique seems important, because, after four weeks of practice, 
there was a strong relationship between vagal tone during breathing exercises and drinking 
capacity.  
Vagal activity is reduced during stress, giving physiological consequences similar to 
vagotomy; reduced antral motility and impaired gastric accommodation (3, 4). Pancreatic 
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polypeptide is reduced in patients with functional dyspepsia and in patients with diabetic 
autonomic neuropathy (92, 101). After vagotomy, there is very low pancreatic polypeptide 
secretion in response to meals (92). Vagotomy and diabetic autonomic neuropathy are 
irreversible conditions, while attenuated vagal activity due to stress may be reversible. Some 
patients with functional dyspepsia might have come to the third phase of stress reaction, the 
phase of exhaustion (67), making improvements hard to take place. The treatment of vagal 
biofeedback with breathing exercises thus might be most effective early in the progression of 
the functional dyspepsia disorder. 
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Summary and Conclusions 
Paper I suggests that breathing exercises for increasing vagal activity would benefit patients 
with functional dyspepsia. In paper II a drink test was developed to discriminate between 
healthy subjects and patients with functional dyspepsia, and the drinking capacity was an 
effect variable that could be used for evaluating the influence of vagal stimulation on gastric 
function. In paper III, invasive vagal stimulation was tested in healthy subjects, using the 
drink test developed in paper II. Paper IV was the realisation of the idea that improving the 
low vagal tone found in patients with functional dyspepsia using breathing exercises and 
vagal biofeedback would increase their low drinking capacity. The non-invasive drink test, 
using a meat soup meal with an ingestion rate of 100 ml/min until maximal satiety, seems 
promising for characterisation of functional dyspepsia and for evaluation of treatment. 
However, for use in clinical practice, further validation of the test is warranted. 
Is functional dyspepsia a lifestyle disorder? Lifestyle is more than general relaxation 
and the rate by which a meal is ingested as investigated in this work. Thus a complete answer 
to this question cannot be given. However, stress is important in many lifestyle diseases, and 
stress might be one of the factors that induce functional dyspepsia. The link between stress, 
vagal activity and stomach function is not new (4). The new in this work is that treatment, 
aiming to lower tension and stress, using simple breathing exercises without any adverse 
events, does improve stomach function and quality of life in these patients. Hence, functional 
dyspepsia might be considered as a lifestyle disorder.  
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